News and Announcements
Get your advanced finance and markets app now
- Published November 02, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Grafa contains AI-curated video news content from Bloomberg, Reuters and CBC Business among others, as well as charting functionality to identify trends across more than 20,000 data sets.
Grafa is the first and last mobile finance app people will check the moment they wake up and before they go to bed.
Wholesale Investor Special Offer
- Early access and 5-year licence to Grafa for a one-off price of US$150 for first 1,000 members (starting price at launch will be US$10 per month).
- Access to all new features and functionality during the 5-year period for no additional cost (higher pricing options will be introduced as advanced functionality and new features are added).
- Sign up today and refer a mate to get the Grafa signature gift pack – Wandering Distillery Signature Gin, Grafa insulated keep cup, Grafa cap.
Unrivalled Features
- AI-generated video news content from Bloomberg, Reuters, Fox Business and more.
- Charting tool that allows for comparisons across 20,000 data points including stock market, economic, commodities, currencies and digital currencies data.
- Like a pocket MBA – entertaining video tutorials that simply explain complex financial concepts.
- Portfolio tracking – monitor the performance of your investments in one place.
Grafa will be launching later this month.
As an early member, you will have the opportunity to help shape the ongoing development of the platform. Grafa is already incredible, but it’s only going to get better! This is your chance to get in on the ground floor and benefit from the upside.
Company Updates
The $3 Billion Blind Spot: How Venstra Medical is using “Collapsible” Physics to Challenge a Global Med-Tech Giant
In the high-stakes theater of the cath lab, cardiogenic shock is the ultimate emergency. Now, a PhD in fluid mechanics and a frontline cardiologist are deploying a “collapsible” breakthrough to disrupt a 30-year monopoly. The Engineer’s Mission For Dr. Martin Cook, the stakes of medical engineering aren’t measured in blueprints, but in heartbeats. A PhD […]
The Blue-Collar ‘Muscle’ Behind Australia’s $100bn Pipeline: One Key Resources Eyes Expansion
As Australia faces a “perfect storm” of low unemployment and an ambitious $100bn project pipeline, One Key Resources MD Ben Lewis explains why the next five years will be defined by the “muscle power” required to deliver the nation’s energy and infrastructure goals.
Off-the-Shelf, On-the-Money: How a Melbourne Biotech is Expanding its Oncology Platform to Endometriosis
Cartherics is bridging the gap in women’s health by utilising iPSC-derived Natural Killer cells to target both ovarian cancer and endometriosis. With a proprietary manufacturing facility and a lead candidate heading to Phase 1 trials, the company is industrialising cell therapy to solve a multi-billion dollar unmet need.
Backed By Leading Investment Groups and Family Offices
